This inventor holds 2 USPTO granted patents and 7 published patent applications and 5 EPO patents. Top assignees: Calimmune Australia Pty Ltd, Calimmune, Inc., Csl Behring Gene Therapy, Inc.. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 3 
1 out of 5 Years Active: 2019-2022
Title: Innovations of Louis Randall Breton
Introduction
Louis Randall Breton is an accomplished inventor based in Tucson, AZ. He holds two patents that contribute significantly to the field of T-cell therapy. His work focuses on advancing medical technologies aimed at improving patient outcomes.
Latest Patents
Breton's latest patents include a modulatable switch for the selection of donor modified cells. The disclosed methods are generally directed to preventing, treating, suppressing, controlling, or otherwise mitigating side effects of T-cell therapy. This therapy is designed to accelerate immune reconstitution, induce a GVM effect, and target tumor cells effectively.
Career Highlights
Throughout his career, Breton has made notable contributions to the field of biotechnology. He has worked with companies such as Calimmune, Inc. and Calimmune Australia Pty Ltd, where he has applied his innovative ideas to real-world applications.
Collaborations
Some of his coworkers include Christopher Walter Alma and Jeffrey S. Bartlett. Their collaborative efforts have furthered the development of technologies in the realm of T-cell therapy.
Conclusion
Louis Randall Breton's contributions to the field of T-cell therapy through his patents and collaborations highlight his role as a significant innovator in medical technology. His work continues to pave the way for advancements in patient care and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile